ASIA Pharmaceutical Industries is one of the pioneering pharmaceutical companies in Syria and the Middle East. Within two decades, a dedicated and highly qualified team of scientists and healthcare professionals has developed a world-class company that has been awarded international quality certificates: cGMPs, ISO 9001, ISO 14001 as well as the OHSAS 18001. The ASIA portfolio(490 pharmaceutical products) encloses a broad range of generic and in-licensed solid, hormones, sterile injectables, serums, Lyophilized, and biotech products starting with Insulin and Erythropoietin. ASIA is operating manufacturing plants in Syria, Algeria, Iraq, Russia and Romania. ASIA has started its operations in 1989, and since then had proved itself as one of the most technology driven and up to date pharmaceutical company, ASIA was able to produce Hormones in solid form since 1993, sterile products, soft-gelatin capsules and herbal medicines were introduces in 2000. In the year 2005, ASIA was able to distinguish itself as a bio-technology pioneer by introducing Human-Insulin. In 2010 through its hard work ASIA was able to produce Hormone medicines in injectable forms. Late 2011 ASIA launched its state of art Serums and single dose eye drops plant s to be one of the leading companies for these forms in the region. Dr. Abdul Muhsen Al-Soukhni (GM of ASIA) has announced recently the investing plan in developing and producing Oncology products, in addition penetrating the sector of vaccines.